MBL2 and pneumococcal pneumonia: Our findings strongly suggest that there are no significant, clinically meaningful associations between MBL genotypes and either 28-day or 6-month survival from sepsis, or susceptibility to CAP or pneumococcal pneumonia in immune competent adults.